Patents Assigned to Bioralix B.V.
  • Patent number: 11793758
    Abstract: The disclosure relates, among others, to methods for preparing pharmaceutical compositions that can be provided to the subject in oral form, comprising as an active ingredient: a protein with a mass of 10 kilodalton or more, a nucleic acid molecule of 15 nucleotides or more, or a combination thereof. The one or more active ingredients are distributed in particles in a way that facilitates the uptake of the particles by the intestine and the release of the active ingredient(s) into the blood stream.
    Type: Grant
    Filed: June 21, 2019
    Date of Patent: October 24, 2023
    Assignee: Bioralix B.V.
    Inventors: Bernardus Rademaker, Willem Adriaan Minnaard, Eduard Johannes Van Zwieten, Jacob Wieling